Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Induction and molecular signature of pathogenic TH17 cells.

Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA, Sobel RA, Regev A, Kuchroo VK.

Nat Immunol. 2012 Oct;13(10):991-9. doi: 10.1038/ni.2416. Epub 2012 Sep 9.

2.

Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling.

Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N, Grainger JR, Chen Q, Kanno Y, Watford WT, Sun HW, Eberl G, Shevach EM, Belkaid Y, Cua DJ, Chen W, O'Shea JJ.

Nature. 2010 Oct 21;467(7318):967-71. doi: 10.1038/nature09447.

3.

The effects of TGF-βs on immune responses.

Komai T, Okamura T, Yamamoto K, Fujio K.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(1):51-8. doi: 10.2177/jsci.39.51. Review.

4.

Th17 cells, pathogenic or not? TGF-β3 imposes the embargo.

Sharma M, Kaveri SV, Bayry J.

Cell Mol Immunol. 2013 Mar;10(2):101-2. doi: 10.1038/cmi.2012.72. Epub 2013 Feb 11. No abstract available.

5.

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.

Singh B, Schwartz JA, Sandrock C, Bellemore SM, Nikoopour E.

Indian J Med Res. 2013 Nov;138(5):591-4. Review.

6.

Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.

Lee PW, Yang Y, Racke MK, Lovett-Racke AE.

Brain Behav Immun. 2015 May;46:44-9. doi: 10.1016/j.bbi.2014.12.007. Epub 2014 Dec 10.

7.

Unexpected targets and triggers of autoimmunity.

Lee Y, Collins M, Kuchroo VK.

J Clin Immunol. 2014 Jul;34 Suppl 1:S56-60. doi: 10.1007/s10875-014-0040-5. Epub 2014 May 1. Review.

8.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK.

Nature. 2006 May 11;441(7090):235-8. Epub 2006 Apr 30.

PMID:
16648838
9.

Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.

Yu X, Guo R, Ming D, Su M, Lin C, Deng Y, Lin Z, Su Z.

J Gastroenterol Hepatol. 2014 May;29(5):1065-72. doi: 10.1111/jgh.12459.

PMID:
24236690
10.

Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection.

Wang B, Dileepan T, Briscoe S, Hyland KA, Kang J, Khoruts A, Cleary PP.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5937-42. doi: 10.1073/pnas.0904831107. Epub 2010 Mar 15.

11.

[The protective role of interleukin-6 monoclonal antibody on experimental autoimmune myocarditis and its mechanism].

He S, Han LN, Wang YT, Liu JW, Ding GL.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2014 Mar;30(2):119-23. Chinese.

PMID:
25016860
12.

[Research progress on Th17 cells].

Zhang W, Luo FJ, Zhou JJ.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Nov;36(6):620-5. Review. Chinese.

PMID:
18067239
13.

IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.

Kastirr I, Maglie S, Paroni M, Alfen JS, Nizzoli G, Sugliano E, Crosti MC, Moro M, Steckel B, Steinfelder S, Stölzel K, Romagnani C, Botti F, Caprioli F, Pagani M, Abrignani S, Geginat J.

J Immunol. 2014 Oct 1;193(7):3322-31. doi: 10.4049/jimmunol.1400775. Epub 2014 Aug 29.

14.
15.

Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells.

Cai Z, Zhang W, Yang F, Yu L, Yu Z, Pan J, Wang L, Cao X, Wang J.

Cell Res. 2012 Mar;22(3):607-10. doi: 10.1038/cr.2011.196. Epub 2011 Dec 13. No abstract available.

16.

Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.

Burkett PR, Meyer zu Horste G, Kuchroo VK.

J Clin Invest. 2015 Jun;125(6):2211-9. doi: 10.1172/JCI78085. Epub 2015 May 11. Review.

17.

TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23.

Morishima N, Mizoguchi I, Takeda K, Mizuguchi J, Yoshimoto T.

Biochem Biophys Res Commun. 2009 Aug 14;386(1):105-10. doi: 10.1016/j.bbrc.2009.05.140. Epub 2009 Jun 6.

PMID:
19501566
18.

Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway.

Fitch EL, Rizzo HL, Kurtz SE, Wegmann KW, Gao W, Benson JM, Hinrichs DJ, Blauvelt A.

J Invest Dermatol. 2009 Oct;129(10):2443-50. doi: 10.1038/jid.2009.88. Epub 2009 Apr 9.

19.

Stellate Cell Activation and Imbalanced Expression of TGF-β1/TGF-β3 in Acute Autoimmune Liver Lesions Induced by ConA in Mice.

Wang L, Tu L, Zhang J, Xu K, Qian W.

Biomed Res Int. 2017;2017:2540540. doi: 10.1155/2017/2540540. Epub 2017 Jan 29.

20.

Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1.

Mesturini R, Gigliotti CL, Orilieri E, Cappellano G, Soluri MF, Boggio E, Woldetsadik A, Dianzani C, Sblattero D, Chiocchetti A, Yagi J, Rojo JM, Dianzani U.

Cytokine. 2013 Oct;64(1):322-30. doi: 10.1016/j.cyto.2013.05.021. Epub 2013 Jun 15.

Supplemental Content

Support Center